Diagonal Bio AB — Investor Relations & Filings

Diagonal Bio AB is a biotechnology company that develops diagnostic technologies. The company's core product is the Panviral platform, a point-of-care system designed for the rapid and accurate detection of genetic markers from pathogens such as viruses, bacteria, and fungi. The technology enables on-site sample analysis, providing results in under 15 minutes. A key feature of the platform is its patented method that allows for the exceptionally fast development of new tests. The company's initial focus is on the veterinary market, offering diagnostic solutions for common viruses in horses and other animals.